AD013 是cACE/NEP的双重抑制剂。AD013 是基于先前报道的 C 域选择性 ACE 抑制剂赖诺普利-色氨酸合成的。AD013 具有提供强效抗高血压和心脏保护作用的潜力。

AD013 is a dual inhibitor of cACE / NEP. AD013 is synthesized based on the previously reported C-domain selective ACE inhibitor lisinopril-tryptophan. AD013 has the potential for providing the potent antihypertensive and cardioprotective benefits [1].

C24H28N2O5

424.49

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years